Skip to content

Prostate Cancer Health and Fitness Online: A pilot randomised controlled trial investigating an online website for prostate cancer survivors to improve their physical activity

Prostate Cancer Health and Fitness Online: The use of computer-tailored web-based interventions for promoting physical activity among prostate cancer survivors: implications of design on feasibility, engagement and potential for efficacy.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000808246
Acronym
PCHF
Enrollment
77
Registered
2018-05-11
Start date
2018-09-10
Completion date
2019-02-04
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is testing a website-based intervention to encourage survivors of prostate cancer to increase their physical activity which has previously been shown to be effective in relieving cancer survivor burden Who is it for? You may be eligible for this study if you have previously been diagnosed with prostate cancer (non-metastatic) and are currently in remission. Study details Participants will be randomised (by chance) into three groups. One group will be offered the website in a stepped fashion, with modules being unlocked as the previous one is completed. The second group will be offered the complete website in a free-choice manner. The third group will be offered the website after a brief wait (4 weeks). The modules will be delivered over a 4 week period. All participants will complete a number of questionnaires about their physical activity and their experience of the website. This study aims to lay some groundwork for the use of web-based interventions targeting physical activity in prostate cancer survivors.

Interventions

This is a 3 armed pilot randomised controlled trial, randomised in 1:2:2 in blocks of 6 by a computer generator. Arm 1: Tunneled computer-tailored website: 4 modules delivered weekly for 4 weeks. Participants allocated to this group will have access to a computer-tailored intervention containing modules that are delivered sequentially and unlocked over time as each module is completed over a 4 week period. The modules will be designed to encourage participation in physical activity by influen

This is a 3 armed pilot randomised controlled trial, randomised in 1:2:2 in blocks of 6 by a computer generator. Arm 1: Tunneled computer-tailored website: 4 modules delivered weekly for 4 weeks. Participants allocated to this group will have access to a computer-tailored intervention containing modules that are delivered sequentially and unlocked over time as each module is completed over a 4 week period. The modules will be designed to encourage participation in physical activity by influencing key determinants of physical activity behaviour, as per Social Cognitive Theory. Four modules will be developed and delivered over 4 weeks. The participants in the tunneled group will be asked to complete one module a week and to record their activity over the week until the next module is unlocked. Each module will take approximately 20 min, with opportunities for more interaction if the participant desires. We will have a 'library' tab of the website where participants can find articles regarding prostate cancer and exercise evidence, and access to videos of different resistance based exercises. The modules focus on increasing knowledge, building goals, facing and overcoming barriers, social support and building long-term physical activity habits. This group will have access to a page on the website where they can submit questions to an exercise physiologist. We will then generate a frequently asked questions section as part of the website. The exercise physiologist will have input over any advice in the tailored messages given by the program to ensure the advice is sound and appropriate. Participants will be monitored by website analytics: modules completed, sign-ins, number of minutes spent on the website. Participants will also be directed to current cancer exercise information as the wait list control. Arm 2: Free-set-up computer-tailored modules: Participants allocated to this group will have access to the same computer-tailored modules as those allocated to the tunnelled condition. The difference is that all modules will be available from the beginning and can be completed in any order, Participants will be encouraged to interact with the site as little or as much as they like: the key here is to improve autonomy in terms of how participants interact. . Participants will be monitored by website analytics: modules completed, sign-ins, number of minutes spent on the website. Participants will also be directed to current cancer exercise information as the wait list control.

Sponsors

Freemasons Foundation Centre for Men's Health
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants must have been previously diagnosed with prostate cancer, have completed active prostate cancer treatment (e.g., surgery, radiotherapy), and currently be in remission. Participants will also be required to read and write fluently in English, not already be participating in 150 minutes of aerobic activity per week or more than 2 sessions of resistance-training, have access to a computer and the internet and have no medical contradictions to exercise. Men who have completed active treatment but are undergoing hormone treatment as a preventive measure are eligible

Exclusion criteria

Men who have not received active treatment (such as those on active surveillance), who are awaiting or currently undertaking active treatment with curative intent, or who are currently living with advanced or metastatic cancer will not be eligible to participate

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026